Nanotechnology firm to form ophthalmology company

Liquidia Technologies, a nanotechnology-based health care company, will form a new ophthalmology business to move into a high-growth therapeutic area, according to a company news release. The company’s likely lead product is a glaucoma treatment that is expected to enter clinical trials in 2014, the release said.The company uses a proprietary technology platform, called Print, to allow for rapid development and production of precisely engineered particles of almost any size, shape and composition. Liquidia will release additional details on the ophthalmic company later in the second quarter, according to the (Read more...)

Full Story →